NCT04765813

Use of a Smartphone Application (App) to Assist a Cognitive-Behavioral Smoking Cessation Treatment

Name: Clinical Trial NCT04765813
Creator: University of Santiago de Compostela
Keywords: Smoking, Cognitive-behavioral treatment to quit smoking along with an App with active therapeutic components, behavioral, clinical trial, Spain

A Randomized Clinical Trial to Assess the Efficacy of a Psychological Treatment to Quit Smoking Assisted With an App

University of Santiago de Compostela·ClinicalTrials.gov·behavioralRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Smoking
Drug/Device/Intervention: Cognitive-behavioral treatment to quit smoking along with an App with active therapeutic components
Study type: Interventional
Intervention type: behavioral

Sponsor & location

Primary sponsor: University of Santiago de Compostela
Location: Santiago de Compostela, Spain

Timeline & enrollment

Phase: N/A
Start date: Sep 15, 2021
End date: Jun 01, 2023
Enrollment: 270 participants

Primary outcome

Point-prevalence abstinence

Summary

This randomized controlled clinical trial examines the effectiveness of a face-to-face* cognitive-behavioral behavioral treatment to quit smoking enriched with an App. This project aims to innovate in the psychological smoking cessation treatment and increase abstinence rates in the short and long term.  * Due to the COVID-19 the face-to-face treatment will be conducted in an online format.

ICD-10 classifications

Tobacco useExposure to tobacco smokeToxic effect: Tobacco and nicotineMental and behavioural disorders due to use of tobacco : harmful useDrug use

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT04765813
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT04765813 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Santiago de Compostela and is currently Recruiting. The study focuses on Smoking. Target enrollment is 270 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.